| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6063008 | Journal of Allergy and Clinical Immunology | 2015 | 18 Pages |
Abstract
A symptom- plus Feno-driven strategy reduces asthma medication use while sustaining asthma control and quality of life and is the preferred strategy for adult asthmatic patients in primary care.
Keywords
Medication Adherence Report ScaleQALYFeNOEQ-5DACQICSQuality of lifePCAasthma exacerbationsLong-acting β-agonistCost-effectivenesspractice nurseFraction of exhaled nitric oxidequality-adjusted life yearLABAMarsFcaGOALAsthma Control QuestionnaireGeneral practitionerAsthma controlInhaled corticosteroid
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Persijn J. MD, Rik J.B. MD, Evelien H. MD, Jiska B. PhD, Wilbert B. PhD, Moira J. RN, Willem J.J. MD, PhD, Gerben PhD, Peter J. MD, PhD, Tjard R.J. PhD, Jacob K. PhD,